• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) UNK TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) UNK TISSUE EXPANDER; EXPANDER, SKIN, INFLATABLE Back to Search Results
Catalog Number UNK TISSUE EXPANDER
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Unspecified Infection (1930); Ischemia (1942); Seroma (2069)
Event Date 05/21/2020
Event Type  Injury  
Manufacturer Narrative
Article citation: ¿risk factors for capsular contracture: a retrospective study in immediate reconstruction versus delayed reconstruction;¿ maiko de kerckhove, md, phd, yoshiko iwahira, md, phd; wolters kluwer health inc.; prs global open 2020; 21 may 2020; the american society of plastic surgeons 2020.(b)(4).The events of seroma, infection (unknown onset), ischemia, wound dehiscence, necrosis, exposure and capsular contracture are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reason for reoperation: seroma, infection (unknown onset), ischemia, wound dehiscence, necrosis, exposure and capsular contracture grade iii-iv.
 
Event Description
Journal article ¿risk factors for capsular contracture: a retrospective study in immediate reconstruction versus delayed reconstruction¿ reported complications following delayed ¿expander insertion¿ of ¿hematoma, seroma, infection, ischemic skin wound, exposure occurrence.¿ patient was considered to experience hematoma ¿if history of hematoma removal or a subcutaneous hemorrhage beyond the dissection area¿ and skin ischemia ¿judged to be present in the case of necrosis or dehiscence of the wound margin or nipple areola regions.¿ baker grade iii or iv was diagnosed for all patients with capsular contracture formation.The tissue expander was explanted after 7 months.Events occurred on an unknown side.This record captures the 27 patients with an allergan expander where surgery was delayed.The event of hematoma is deemed to be not related to the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK TISSUE EXPANDER
Type of Device
EXPANDER, SKIN, INFLATABLE
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
Manufacturer (Section G)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS  
Manufacturer Contact
michelle burgess
12331-a riata trace parkway
building 3
austin, TX 78727
7372473605
MDR Report Key10986587
MDR Text Key220770733
Report Number9617229-2020-20583
Device Sequence Number1
Product Code LCJ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K862203
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 12/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK TISSUE EXPANDER
Was Device Available for Evaluation? No
Date Manufacturer Received11/11/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CHEMOTHERAPY, HORMONE THERAPY, AND RADIATION
Patient Outcome(s) Required Intervention;
-
-